BioXcel Therapeutics Inc (BTAI) operating margin is -49.6%
BioXcel Therapeutics Inc (BTAI) operating margin is -49.6% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full BTAI research page for quote, filings, and the rest of the model. This satellite exists so “BioXcel Therapeutics Inc operating margin” can rank with the actual number, then send you to /stock/btai.